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Abstract
To determine whether genetic heterogeneity exists in patients with Graves’ disease (GD), the cytotoxic T-lymphocyte
associated 4 (CTLA-4) gene, which is implicated a susceptibility gene for GD by considerable genetic and immunological
evidence, was used for association analysis in a Chinese Han cohort recruited from various geographic regions. Our
association study for the SNPs in the CTLA4 gene in 2640 GD patients and 2204 control subjects confirmed that CTLA4 is the
susceptibility gene for GD in the Chinese Han population. Moreover, the logistic regression analysis in the combined
Chinese Han cohort revealed that SNP rs231779 (allele frequencies p=2.81610
29, OR=1.35, and genotype distributions
p=2.75610
29, OR=1.42) is likely the susceptibility variant for GD. Interestingly, the logistic regression analysis revealed that
SNP rs35219727 may be the susceptibility variant to GD in the Shandong population; however, SNP, rs231779 in the CTLA4
gene probably independently confers GD susceptibility in the Xuzhou and southern China populations. These data suggest
that the susceptibility variants of the CTLA4 gene varied between the different geographic populations with GD.
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Introduction
Graves’ disease, which affects 1.2% of western populations
(0.5% clinical and 0.7% subclinical) [1] and 0.25–1.09% of the
Chinese population [2], is an autoimmune disorder in which the
body produces auto-antibodies to the receptor for thyroid-
stimulating hormone (TSH), leading to hyperthyroidism. Although
environmental agents, such as infection [3] and stress, are
undoubtedly important in the development of Graves’ disease in
susceptible individuals, it has been estimated in twin studies that
around 80% of the predisposition to GD is due to genetic factors
[4]. However, similar to other common complex diseases, the
identification of the susceptibility gene for GD has been
challenging. Recently, genome-wide association studies (GWAS)
have uncovered the susceptibility genes of some common diseases
[5–8]. However, variability between studies in the measured
significance of the validated loci has appeared, and has suggested
that genetic heterogeneity exists in type 2 diabetes [5–8]. In a
recent whole genome linkage study by Tomer Y., distinct genes
were suggested to predispose to autoimmune thyroid diseases
(AITD) in different subsets of patients [9]. Most recently, our data
have shown that, similar to most Mendelian monogenic disorders,
the susceptibility variants of a gene that predisposes to GD varied
among patients from different geographic populations [10]. The
goal of the present study was to confirm that genetic heterogeneity
exists in patients with GD.
Many genetic approaches, including candidate gene association
studies [10–18] and GWAS [19] have been applied to identify
genetic variants predisposing to GD, and several genes have
been proposed as candidates, including Fc receptor-like 3 (FCRL3)
[12],CD40 [14], human leukocyte antigen (HLA) [15], cytotoxic T
lymphocyte antigen 4 (CTLA-4) [16,18], protein tyrosine phosphatase, non-
receptor type 22 (PTPN22) [17], thyroid-stimulating hormone receptor
(TSHR) [11,20], the small antisense transcript of zinc-finger gene (SAS-
ZFAT) [13], and Secretoglobin Family 3A Member 2 (SCGB3A2) [10].
However, most of these candidate susceptibility genes have been
proven to be controversial. Only the HLA region on chromosome
6p21 [11,19] and the CTLA-4 gene on chromosome 2q33 [21–28]
have been extensively studied, and considerable genetic and
immunological evidence has suggested that they are important for
GD. Furthermore, several SNPs, such as A49G, CT60, JO31 in
the CTLA-4 gene, rather than in CD28 gene have been revealed
association with Graves’ disease [21–28].
In the present work, in order to confirm that CTLA4 gene is
associated with GD, and to ask whether the susceptibility variants
in the gene differed among the different geographic populations
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Populations Combined Shandong
SNP Allele control (%) case (%) p Value OR OR (95%CI) control (%) case (%) p Value OR OR (95%CI)
rs11571315 A 3063 (71.8) 3890 (76.3) 4.65610
26 1.26 1.15–1.39 948 (71.2) 1407 (76.4) 0.0022 1.31 1.12–1.54
G 1201 (28.2) 1206 (23.7) 384 (28.8) 435 (23.6)
rs4553808 A 3304 (86.7) 4274 (88.6) 0.0127 1.19 1.05–1.36 1109 (88.9) 1575 (88.4) 0.7068 0.95 0.76–1.20
G 506 (13.3) 548 (11.4) 139 (11.1) 207 (11.6)
rs11571316 C 3048 (80.3) 3714 (83.5) 0.0004 1.25 1.11–1.39 984 (79.1) 1106 (79.6) 0.7842 1.03 0.85–1.24
T 748 (19.7) 732 (16.5) 260 (20.9) 284 (20.4)
rs231775 G 2713 (70.5) 2790 (74.8) 9.39610
25 1.24 1.12–1.38 849 (71.2) 783 (75.7) 0.0271 1.26 1.04–1.52
A 1135 (29.5) 938 (25.2) 343 (28.8) 251 (24.3)
rs231777 C 3320 (86.1) 4294 (87.8) 0.0288 1.16 1.03–1.32 1109 (88.7) 1603 (87.5) 0.3449 0.89 0.71–1.11
T 536 (13.9) 596 (12.2) 141 (11.3) 229 (12.5)
rs35219727 G 3500 (92.0) 4485 (91.9) 0.9792 1.00 0.85–1.17 1207 (96.9) 1693 (92.9) 1.30610
25 0.42 0.29–0.61
A 306 (8.0) 393 (8.1) 39 (3.1) 129 (7.1)
rs231779 T 2903 (69.2) 3837 (75.2) 2.81610
29 1.35 1.23–1.48 875 (70.2) 1409 (75.7) 0.0019 1.32 1.12–1.55
C 1293 (30.8) 1267 (24.8) 371 (29.8) 453 (24.3)
rs231723 G 3457 (72.4) 3674 (76.5) 2.55610
25 1.24 1.13–1.36 945 (70.9) 1455 (75.9) 0.0038 1.29 1.10–1.51
A 1317 (27.6) 1130 (23.5) 387 (29.1) 463 (24.1)
rs10197010 A 3259 (84.6) 4193 (86.0) 0.1129 1.11 0.99–1.25 1087 (87.1) 1562 (86.3) 0.5549 0.93 0.75–1.15
C 591 (15.4) 685 (14.0) 161 (12.9) 248 (13.7)
rs231725 A 2431 (63.0) 3329 (68.2) 2.86610
26 1.26 1.15–1.38 799 (64.0) 1231 (67.6) 0.0602 1.17 1.01–1.36
G 1427 (37.0) 1553 (31.8) 449 (36.0) 591 (32.4)
rs11571302 C 3336 (77.8) 4246 (81.6) 2.29610
25 1.26 1.14–1.40 992 (77.0) 1563 (81.4) 0.0052 1.31 1.10–1.55
A 952 (22.2) 958 (18.4) 296 (23.0) 357 (18.6)
rs231729 A 2718 (63.2) 3547 (68.2) 2.61610
26 1.25 1.15–1.36 824 (63.9) 1298 (68.0) 0.0244 1.20 1.04–1.40
T 1580 (36.8) 1653 (31.8) 466 (36.1) 610 (32.0)
rs231730 T 3745 (86.5) 4494 (87.4) 0.2671 1.08 0.95–1.21 1166 (87.4) 1638 (87.0) 0.7745 0.97 0.78–1.19
A 583 (13.5) 650 (12.6) 168 (12.6) 244 (13.0)
rs231731 T 3662 (85.0) 4496 (86.4) 0.0735 1.12 1.00–1.26 1111 (85.6) 1644 (85.9) 0.8254 1.02 0.84–1.25
C 648 (15.0) 710 (13.6) 187 (14.4) 270 (14.1)
rs10932025 G 3663 (85.1) 4510 (86.6) 0.0677 1.12 1.00–1.26 1119 (86.2) 1657 (86.5) 0.8383 1.02 0.83–1.26
C 639 (14.9) 700 (13.4) 179 (13.8) 259 (13.5)
Xuzhou Southern
control (%) case (%) p Value OR OR (95%CI) control (%) case (%) p Value OR OR (95%CI)
1098 (67.3) 1251 (74.6) 1.65610
25 1.43 1.23–1.66 1017 (78.2) 1232 (78.1) 0.9253 0.99 0.83–1.18
534 (32.7) 425 (25.4) 283 (21.8) 346 (21.9)
1345 (85.1) 1463 (88.5) 0.0099 1.34 1.09–1.64 850 (86.6) 1236 (89.2) 0.0735 1.28 1.00–1.64
235 (14.9) 191 (11.5) 132 (13.4) 150 (10.8)
1334 (81.6) 1456 (86.7) 0.0003 1.46 1.21–1.76 730 (79.5) 1152 (83.7) 0.0178 1.32 1.07–1.64
300 (18.4) 224 (13.3) 188 (20.5) 224 (16.3)
1082 (67.6) 1245 (74.7) 3.47610
25 1.42 1.22–1.65 782 (74.1) 762 (74.1) 0.9726 1.00 0.83–1.11
518 (32.4) 421 (25.3) 274 (25.9) 266 (25.9)
1356 (83.9) 1457 (87.5) 0.0074 1.34 1.10–1.63 855 (86.4) 1234 (88.6) 0.1223 1.23 0.96–1.58
260 (16.1) 209 (12.5) 135 (13.6) 158 (11.4)
1339 (85.4) 1412 (86.1) 0.5995 1.06 0.87–1.29 954 (96.2) 1380 (97.5) 0.0961 1.53 0.96–2.43
229 (14.6) 228 (13.9) 38 (3.8) 36 (2.5)
1100 (68.7) 1237 (76.1) 1.37610
25 1.45 1.24–1.70 928 (68.8) 1191 (73.7) 0.0071 1.27 1.08–1.49
502 (30.3) 389 (23.9) 420 (31.2) 425 (26.3)
1098 (67.5) 1249 (74.4) 5.37610
25 1.40 1.20–1.63 1414 (77.9) 970 (80.3) 0.1384 1.16 0.97–1.39
528 (32.5) 429 (25.6) 402 (22.1) 238 (19.7)
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Chinese Han cohort containing 2640 patients with GD and 2204
control subjects.
Results
Association analysis of the CTLA4 gene in a combined
Chinese Han population
Forty-seven SNPs in the CTLA4 gene region were selected for
genotyping in the Chinese Han cohort, containing 2640 patients
with GD and 2204 control subjects, which were recruited from
different geographic regions of China. Among the 47 SNPs, 44
SNPs with call rates of more than 80% were further analyzed in
2640 GD patients and 2204 control subjects. Of those, 17 SNPs
with unique alleles and five SNPs with minor allele frequencies
(MAF) of less than 1% were removed from the association analysis.
In addition, seven SNPs with Hardy-Weinberg equilibrium (HME)
of p#1610
26 in controls were also eliminated from the analysis
[29]. Finally, 15 of the 47 SNPs in the CTLA4 gene region were
included in the association analysis (Table S1). The allele
frequencies (Table 1) and the genotype distributions (Table 2)
for these 15 SNPs were analyzed in 2640 GD patients and 2204
control subjects from different geographic regions of China. And
all samples were analyzed in the same lab and under the same
conditions. Out of the 15 SNPs, eight SNPs have significantly
different allele frequencies and genotype distributions (at p-value
,0.001 level) between the GD and normal subjects and the
strongest association was measured for one SNP in the first in-
tron, rs231779 (allele frequencies p=2.81610
29, OR=1.35,
95%CI=1.23–1.48 and genotype distributions p=2.75610
29,
OR=1.42, 95%CI=1.27–1.60) (Tables 1 and 2, Fig. 1A and 1B).
It was interesting that rs231775 (i.e., A49G polymorphism in exon
1 of the CTLA4 gene) and rs11571302 (i.e., JO31 polymorphism in
the 39 untranslated region (UTR) of the CTLA4 gene), which have
been reported to be susceptibility loci of GD, also showed
significant differences between GD patients and controls in the
combined Chinese Han population (rs231775: allele frequen-
cies p=9.39610
25, OR=1.24, 95%CI=1.12–1.38 and geno-
type distributions p=0.0002, OR=1.28, 95%CI=1.13–1.45,
rs11571302: allele frequencies p=2.29610
25, OR=1.26,
95%CI=1.14–1.40 and genotype distributions p=9.26610
26,
OR=1.31, 95%CI=1.16–1.47, respectively) (Tables 1 and 2,
Fig. 1A and 1B).
Meanwhile, the linkage disequilibrium (LD) regions of 15 SNPs
within the CTLA4 gene were evaluated using the Haploview
program [30]. Two LD region composed of these SNPs were
observed in the combined Chinese Han population and were
located between SNPs rs11571315 and rs231777, and SNPs
rs231779 and rs10932025, respectively (Fig. 1G).
Next, to identify the susceptibility variants of GD in the CTLA4
gene region, the genotype data of 15 SNPs suitable for logistic
regression analysis in the combined Chinese Han population were
further mined by forward and two-locus logistic regression analysis
[16,31] (Table 3 and Fig. 1C). Forward logistic regression result
suggested that rs11571316, rs231779, rs231725 and rs231730
were the independent susceptibility variants in the combined
Chinese Han cohorts. Because no statistical difference in allele
frequencies and genotype distributions between GD patients and
healthy control was detected at SNP rs231730, the remained three
SNPs rs11571316, rs231779 and rs231725 were further analyzed
by two-locus regression analysis. Among them, rs231779 can
improve all of the models with one of other 14 SNPs, with a cut-off
p-value ,0.01. Nevertheless, only three SNPs (rs11571316,
rs35219727, and rs231730) could improve this model with SNP
rs231779 (p=3.36610
28, 0.0069 and 0.0022, respectively).
Among the three SNPs that could improve the model with
rs231779, two SNPs (rs35219727 and rs231730) did not show a
significant difference between the patients with GD and control
subjects. Meanwhile, SNP rs11571316 in the promoter of the
CTLA4 gene was located on one of the two LD blocks that did not
include SNP rs231779 (Fig. 1G). Thus, in the combined Chinese
Han population, with regard to the SNPs in the CTLA4 gene
region, SNP rs231779 with the lowest p-value among 15 SNPs of
CTLA4 was likely the most important SNP for the susceptibility to
GD because it could improve the model with each one of other 14
SNPs. However, these results do not exclude the possibility that
Xuzhou Southern
control (%) case (%) p Value OR OR (95%CI) control (%) case (%) p Value OR OR (95%CI)
1330 (82.4) 1411 (84.9) 0.0747 1.20 1.00–1.45 842 (85.2) 1220 (86.8) 0.3192 1.14 0.90–1.44
284 (17.6) 251 (15.1) 146 (14.8) 186 (13.2)
1010 (62.3) 1159 (69.7) 4.50610
25 1.39 1.20–1.60 622 (62.8) 939 (67.3) 0.0383 1.22 1.02–1.44
610 (37.7) 505 (30.3) 368 (37.2) 457 (32.7)
1293 (79.3) 1392 (84.0) 0.0015 1.36 1.14–1.63 1051 (76.7) 1291 (79.4) 0.1022 1.17 0.98–1.39
337 (20.7) 266 (16.0) 319 (23.3) 335 (20.6)
1017 (62.5) 1148 (69.2) 0.0002 1.35 1.17–1.56 877 (63.6) 1101 (67.4) 0.0417 1.18 1.02–1.38
611 (37.5) 510 (30.8) 503 (36.4) 533 (32.6)
1356 (83.1) 1436 (85.6) 0.0688 1.21 1.00–1.46 1223 (89.8) 1420 (89.6) 0.9032 0.98 0.78–1.25
276 (16.9) 242 (14.4) 139 (10.2) 164 (10.4)
1358 (83.1) 1411 (85.5) 0.0801 1.20 0.99–1.45 1193 (86.6) 1441 (87.8) 0.3702 1.11 0.90–1.38
276 (16.9) 239 (14.5) 185 (13.4) 201 (12.2)
1353 (83.0) 1417 (85.4) 0.0874 1.19 0.99–1.44 1191 (86.7) 1436 (87.9) 0.3623 1.11 0.90–1.38
277 (17.0) 243 (14.6) 183 (13.3) 198 (12.1)
The p value with bold letters indicate those allele frequencies with significant differences between GD and normal subjects.
doi:10.1371/journal.pone.0009821.t001
Table 1. Cont.
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Populations Combined Shandong
SNP Genotype control (%) case (%) p Value OR OR (95%CI) control (%) case (%) p Value OR OR (95%CI)
rs11571315 AA 1109 (52.0) 1496 (58.7) 4.39610
26 1.31 1.17–1.47 336 (50.5) 539 (58.5) 0.0014 1.39 1.13–1.69
AG+GG 1023 (48.0) 1052 (41.3) 330 (49.5) 382 (41.5)
rs4553808 AA 1430 (75.1) 1893 (78.5) 0.0075 1.21 1.05–1.40 492 (78.8) 694 (77.9) 0.6569 0.95 0.74–1.21
AG+GG 475 (24.9) 518 (21.5) 132 (21.2) 197 (22.1)
rs11571316 CC 1221 (64.3) 1553 (69.9) 0.0002 1.29 1.13–1.46 383 (61.6) 433 (62.3) 0.7863 1.03 0.83–1.29
CT+TT 677 (35.7) 670 (30.1) 239 (38.4) 262 (37.7)
rs231775 GG 945 (49.1) 1030 (55.3) 0.0002 1.28 1.13–1.45 301 (50.5) 295 (57.1) 0.0287 1.30 1.03–1.65
GA+AA 979 (50.9) 834 (44.7) 295 (49.5) 222 (42.9)
rs231777 CC 1423 (73.8) 1891 (77.3) 0.0068 1.21 1.05–1.39 490 (78.4) 702 (76.6) 0.4170 0.90 0.71–1.15
CT+TT 505 (26.2) 554 (22.7) 135 (21.6) 214 (23.4)
rs35219727 GG 1602 (84.2) 2046 (83.9) 0.7917 0.98 0.83–1.15 586 (94.1) 782 (85.8) 3.57610
–7 0.38 0.26–0.56
GA+AA 301 (15.8) 393 (16.1) 37 (5.9) 129 (14.2)
rs231779 TT 1026 (48.9) 1471 (57.6) 2.75610
29 1.42 1.27–1.60 318 (51.0) 539 (57.9) 0.0078 1.32 1.08–1.62
TC+CC 1072 (51.1) 1081 (42.4) 305 (49.0) 392 (42.1)
rs231723 GG 1252 (52.5) 1413 (58.8) 8.99610
26 1.30 1.16–1.45 227 (33.7) 413 (44.5) 1.51610
25 1.57 1.28–1.93
GA+AA 1135 (47.5) 989 (41.2) 446 (66.3) 516 (55.5)
rs10197010 AA 1368 (71.1) 1810 (74.2) 0.0204 1.17 1.02–1.34 470 (75.3) 676 (74.7) 0.7818 0.97 0.76–1.22
AC+CC 557 (28.9) 629 (25.8) 154(24.7) 229 (25.3)
rs231725 AA 751 (38.9) 1143 (46.8) 1.71610
27 1.38 1.22–1.56 254 (40.7) 411 (45.1) 0.0868 1.20 0.97–1.47
AG+GG 1178 (61.1) 1298 (53.2) 370 (59.3) 500 (54.9)
rs11571302 CC 1293 (60.3) 1731 (66.5) 9.26610
26 1.31 1.16–1.47 379 (58.9) 636 (66.3) 0.0026 1.37 1.12–1.69
CA+AA 851 (39.7) 871 (33.5) 265 (41.1) 324 (33.8)
rs231729 AA 843 (39.2) 1219 (46.9) 1.16610
27 1.37 1.22–1.54 261 (40.5) 440 (46.1) 0.0253 1.26 1.03–1.54
AT+TT 1306 (60.8) 1381 (53.1) 384 (59.5) 514 (53.9)
rs231730 TT 1617 (74.7) 1977 (76.9) 0.0858 1.12 0.98–1.28 507 (76.0) 717 (76.2) 0.9322 1.01 0.80–1.27
TA+AA 547 (25.3) 595 (23.1) 160 (24.0) 224 (23.8)
rs231731 TT 1544 (71.6) 1948 (74.8) 0.0132 1.18 1.03–1.34 470 (72.4) 709 (74.1) 0.4582 1.09 0.87–1.36
TC+CC 611 (28.4) 655 (25.2) 179 (27.6) 248 (25.9)
rs10932025 GG 1549 (72.0) 1959 (75.2) 0.0129 1.18 1.04–1.34 478 (73.7) 718 (74.9) 0.5590 1.07 0.85–1.34
GC+CC 602 (28.0) 646 (24.8) 171 (26.3) 240 (25.1)
Xuzhou Southern
control (%) case (%) p Value OR OR (95%CI) control (%) case (%) p Value OR OR (95%CI)
373 (45.7) 467 (55.7) 4.62610
25 1.49 1.23–1.81 400 (61.5) 490 (62.1) 0.8261 1.02 0.83–1.27
443 (54.3) 371 (44.3) 250 (38.5) 299 (37.9)
573 (72.5) 646 (78.1) 0.0092 1.35 1.08–1.70 365 (74.3) 553 (79.8) 0.0266 1.36 1.04–1.79
217 (27.5) 181 (21.9) 126 (25.7) 140 (20.2)
553 (67.7) 639 (76.1) 0.0001 1.52 1.22–1.88 285 (62.1) 481 (69.9) 0.0059 1.42 1.11–1.82
264 (32.3) 201 (23.9) 174 (37.9) 207 (30.1)
370 (46.3) 467 (56.1) 7.32610
25 1.48 1.22–1.80 274 (51.9) 268 (52.1) 0.9366 1.01 0.79–1.29
430 (53.8) 366 (43.9) 254 (48.1) 246 (47.9)
567 (70.2) 638 (76.6) 0.0033 1.39 1.12–1.73 366 (73.9) 551 (79.2) 0.0347 1.34 1.02–1.76
241 (29.8) 195 (23.4) 129 (26.1) 145 (20.8)
557 (71.0) 592 (72.2) 0.6098 1.06 0.85–1.31 459 (92.5) 672 (94.9) 0.0892 1.50 0.94–2.42
227 (29.0) 228 (27.8) 37 (7.5) 36 (5.1)
391 (48.8) 484 (59.5) 1.55610
25 1.54 1.27–1.88 317 (47.0) 448 (55.4) 0.0013 1.40 1.14–1.72
410 (51.2) 329 (40.5) 357 (53.0) 360 (44.6)
374 (46.0) 465 (55.4) 0.0001 1.46 1.20–1.77 412 (63.7) 534 (68.9) 0.0376 1.26 1.01–1.58
439 (54.0) 374 (44.6) 235 (36.3) 241 (31.1)
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susceptibility to GD.
The false positive report probability (FPRP) of the SNPs with
significant association to GD in the combined Chinese Han cohort
was also analyzed. In the present study, the FPRP value was
calculated for each genetic variant using the assigned prior
probability range, the statistical power to detect an odds ratio of
1.5, and detected odds ratios and p values. As shown in Table 4,
among the 10 genetic variants with a significant difference
between the patients with GD and healthy individuals, the FPRP
values of five SNPs were below 0.2 for the prior probability from
0.25 to 0.0001, which was a relatively high prior probability range.
However, the FPRP values for rs231779 were very low even for
low prior probabilities, since the FPRP value remained below 0.2
even for a prior probability of 0.00001 (Table 4). Interestingly, the
case control study for these 10 SNPs with significant differences in
allele frequencies between the 2640 patients with GD and 2204
control individuals has more than 99.5% statistical power to detect
a SNP with an a level equal to their reported p value,
corresponding to relative risks of 1.5 for GD (Table 4). Notably,
the FPRP values of SNP rs11571316 (p=0.0004), a possible
susceptibility variant for GD in the Chinese Han population by
logistic regression analysis, were below 0.2 just for the prior
probability from 0.25 to 0.01; whereas, the values were more than
0.2 if the prior probability was less than 0.01, suggesting that the
SNP rs11571316 may be a false positive report SNP.
Association analysis in different geographic regions of
the Chinese Han population
It was interesting that there was variability in the significance of
15 SNPs in the CTLA4 gene region across different geographic
regions of the Chinese Han population. In the Shandong
population, there were seven SNPs exhibiting significantly
different allele frequencies and genotype distributions between
970 GD patients and 682 control subjects, with p-values ,0.05
(Tables 1 and 2, and Fig. 1A and 1B). Further analysis of these
seven SNPs revealed that the most significant difference in allele
frequencies and genotype distributions was detected at SNP
rs35219727 (p=1.30610
25, OR 0.42, 95%CI 0.29–0.61 and
p=3.57610
27, OR 0.38, 95%CI 0.26–0.56, respectively) (Tables 1
and 2, and Fig. 1A, 1B), which was also in intron 1 of the CTLA4
gene. Next, these 15 SNPs in the Shandong population were
further analyzed using forward and two-locus logistic regression
analysis. Forward logistic regression result revealed that SNPs
rs11571316, rs231777, rs35219727, rs231779 and rs231723 were
the independent susceptibility variants. However, no statistical
differences were detected at SNPs rs11571316 and rs231777
(Table 1, 2 and Fig. 1A, 1B). At the same time, the two-locus
logistic regression result showed that rs35219727 could improve
the model with each one of the other 14 SNPs; however, only
seven SNPs could weakly improve the model with rs35219727,
except SNP rs11571316 (Table 3 and Fig. 1D), with a cut-off p-
value ,0.01. Although SNP rs11571316 could significantly
improve the model with rs35219727 in the Shandong population
by two-locus logistic regression analysis, it showed no significant
difference between patients with GD and control subjects
(Tables 1, 2 and 3, and Fig. 1D). Interestingly, unlike Xuzhou
and the combined Chinese Han population, only one LD region
was discovered in the Shandong population by haploview analysis.
This region was located between SNPs rs11571315 and
rs10932025 (Fig. 1H). The results suggested that SNP
rs35219727 was the susceptibility variant to GD in the Shandong
population.
Meanwhile, in the Xuzhou population of 841 GD patients and
818 control subjects, out of 15 SNPs, 10 SNPs demonstrated
different distribution patterns (at p-value ,0.01 level) (Tables 1
and 2, and Fig. 1A and 1B). Among those 10 SNPs, five SNPs
(rs11571315, rs231775, rs231779, rs231723, and rs231725)
exhibited statistically significant differences in allele frequencies
and genotype distributions, with the p-values ,0.0001, and the
most significant difference in the allele and genotype frequencies
located at SNP rs231779 (p=1.37610
25, OR 1.45, 95%CI 1.24–
1.70 and p=1.55610
25, OR 1.54, 95%CI 1.27–1.88) (Tables 1
and 2, and Fig. 1A and 1B). Notably, any two loci between these
five SNPs (rs11571315, rs231775, rs231779, rs231723, and
Xuzhou Southern
control (%) case (%) p Value OR OR (95%CI) control (%) case (%) p Value OR OR (95%CI)
544 (67.4) 604 (72.7) 0.0198 1.29 1.04–1.59 354 (71.7) 530 (75.4) 0.1481 1.21 0.93–1.57
263 (32.6) 227 (27.3) 140 (28.3) 173 (24.6)
311 (38.4) 408 (49.0) 1.39610
25 1.54 1.27–1.88 186 (37.6) 324 (46.4) 0.0024 1.44 1.14–1.82
499 (61.6) 424 (51.0) 309 (62.4) 374 (53.6)
517 (63.4) 586 (70.7) 0.0018 1.39 1.13–1.71 397 (58.0) 509 (62.6) 0.0666 1.21 0.99–1.50
298 (36.6) 243 (29.3) 288 (42.0) 304 (37.4)
313 (38.5) 401 (48.4) 5.00610
25 1.50 1.23–1.82 269 (39.0) 378 (46.3) 0.0044 1.35 1.10–1.66
501 (61.5) 428 (51.6) 421 (61.0) 439 (53.7)
562 (68.9) 621 (74.0) 0.0205 1.29 1.04–1.59 548 (80.5) 639 (80.7) 0.9183 1.01 0.78–1.31
254 (31.1) 218 (26.0) 133 (19.5) 153 (19.3)
562 (68.8) 608 (73.7) 0.0280 1.27 1.03–1.58 512 (74.3) 631 (76.9) 0.2504 1.15 0.91–1.45
255 (31.2) 217 (26.3) 177 (25.7) 190 (23.1)
559 (68.6) 611 (73.6) 0.0245 1.28 1.03–1.58 512 (74.5) 630 (77.1) 0.2429 1.15 0.91–1.46
256 (31.4) 219 (26.4) 175 (25.5) 187 (22.9)
The p value with bold letters indicate those genotype frequencies with significant differences between GD and normal subjects.
doi:10.1371/journal.pone.0009821.t002
Table 2. Cont.
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values were greater than 97% (Fig. 1I). Forward logistic regression
revealed that only SNP rs231779 was the independent suscepti-
bility variant. At the same time, two-locus logistic regression
analysis results showed that no SNP can improve the model with
rs231779, however, rs231779 can improve the model with one of
other nine out of 14 SNPs, with a cut-off p value ,0.01 (Table 3).
Interestingly, four out of five SNPs (rs11571315, rs231775,
rs231723, and rs231725), which could not improve the model
with rs231779, were strongly linked in the Xuzhou population and
not the independent susceptibility variants in the forward logistic
analysis. It was possible that SNP rs231779 conferred susceptibility
to GD in the Xuzhou population. Haploview analysis results for
the Xuzhou population revealed that there were two LD blocks
located between SNPs rs11571315 and rs231777, and SNPs
rs231779 and rs10932025, which were the same as the results from
the combined Chinese Han population (Fig. 1I).
At the same time, association analysis was performed in 829 GD
patients and 704 normal subjects from southern China, including
Shanghai City and Fujian Province. We found that four out of 15
SNPs had allele frequencies of significant difference (Table 1) and
seven SNPs had different genotype distributions (Table 2) between
patients with GD and control subjects,with p-values ,0.05.
Among them, the locus with the most significant difference was
located at SNP rs231779, and the p-values for allele frequencies
and genotype distributions were 0.0071 and 0.0013, respectively
Figure 1. The results of association analysis of SNPs in the CTLA4 gene region from different populations. A total of 47 SNPs located in
the CTLA4 gene region were genotyped in all subjects from different geographic regions of China. After removal of the SNPs with minor allele
frequencies (MAF) ,1%, missing data above 20% or HWE p#1610
26 in the controls, the allele frequencies (A) and genotype distributions (B)i nG D
and control subjects from different populations were plotted [2log10(p value) against location]. The most significantly associated SNPs in the
combined Chinese Han, Xuzhou, and southern populations were all located at rs231779, with the smallest p values of 2.81610
29, 1.37610
25, 0.0071
in allele frequency difference (A) and 2.75610
29, 1.55610
25, 0.0013 in genotype distributions (B), respectively. In the Shandong population the most
significantly locus was located at rs35219727, with the smallest p values of 1.30610
25 in allele frequencies (A) and 3.57610
27 in genotype
distributions (B) (see Tables 1 and 2 for detailed information). C–F: Two-locus logistic regression analyses of rs231779 in the combined Chinese Han
population (C), rs35219727 in the Shandong population (D), rs2321779 in the Xuzhou population (E) and rs231779 in the Southern China population
(F). SNPs rs231779 and rs35219727were put individually into the regression models as the best makers, and all other markers were sequentially added
to see if a second locus could improve the model. In the combined Chinese Han population, three of the 14 SNPs suitable for logistic regression
analysis hurt the model with rs231779 (C), at the p value ,0.01. In contrast, we tested a regression model by taking each of 14 loci in turn and adding
the test locus to it. All the markers could be improved by adding rs231779 (C). At the same time, in the Shandong population, rs35219727 improved
the model with each of the other 14 SNPs; however, seven SNPs hurt the model with rs35219727, except SNP rs11571316 (D) (see Table 3 for detailed
information). In the Xuzhou and Southern China populations, most of the models with other SNPs could be improved by adding SNP rs231779,
however, no or only two SNPs can improve the model with rs231779 (E, F). G–J: The SNPs linkage disequilibrium (LD) region for the Combined
Chinese Han (G), Shandong (H), Xuzhou (I) and the southern China (J) populations in the CTLA4 gene region were analyzed with haploview software.
doi:10.1371/journal.pone.0009821.g001
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PLoS ONE | www.plosone.org 7 March 2010 | Volume 5 | Issue 3 | e9821(Tables 1 and 2). Forward logistic regression result suggested that
SNPs rs11571315, rs231775 and rs231779 were the independent
susceptibility variants. However, there were no statistical differ-
ences between GD patients and control subjects at SNPs
rs11571315 and rs231775. Meanwhile, the two-locus logistic
regression analysis in the southern China population revealed that
rs231779 can improve the model with each of SNPs except three
SNPs (rs11571316, rs11571302 and rs231729), however, only
three SNPs (rs11571315, rs231775 and rs231730) can improve the
model with SNP rs231779. Interestingly, the three SNPs
improving the model with rs231779 did not show a significant
difference between the patients with GD and control subjects
recruited from southern China. Of note, SNPs rs11571316 and
rs231779 were linked to each other (D’=82%) in the southern
China population by haploview analysis (Fig. 1J), but they did not
influenced each other in the results of the two-locus logistic
regression analysis (Table 3). Taken together these results
suggested that SNP rs231779, in the CTLA4 gene independently
conferred susceptibility to GD in the southern China population.
Discussion
Our case-control study of the SNPs in the CTLA4 gene region
from 2640 GD patients and 2204 control subjects verified that
CTLA4 is the susceptibility gene for GD in the Chinese Han
population. Moreover, the logistic regression analysis in the
combined Chinese Han cohorts revealed that SNP rs231779 is
likely the susceptibility variant because it improved the model with
any one of the other 14 SNPs in the CTLA4 gene region.
Interestingly, the FPRP value for SNP rs231779 was very low for
the prior probability range and was quite robust even for low prior
probabilities. These results suggest that rs231779 in intron 1 of
CTLA4 is associated with GD etiology in the combined Chinese
Han population; although, it still remains possible that there are
other susceptibility SNPs or gene(s) that cause the onset of GD.
Similarly, SNP rs231779 was associated with susceptibility to GD
in the Shanghai Han population of China with 436 patients with
GD and 316 control subjects (allele frequency p=0.013, OR 1.34,
95%CI 1.06–1.68 and genotype distribution p=0.017, OR 1.44,
95%CI 1.07–1.93) [28] and in the Taiwan population with 208
Chinese GD patients and 171 healthy controls (genotype
distribution p=0.0008) [26].
The SNPs, rs231775 (Exon 1 +49G.A) [21–23,26,32] and
rs3087243 (CT60) [16,25,28], have been previously reported to be
the major susceptibility variant of GD in Europe Caucasian
populations. In our present study, SNP rs231775, which was
almost perfectly linked with rs231779 (D’ value, 0.88,0.97 in the
combined Chinese Han and three different populations), showed a
significant difference between GD patients and controls in the
combined Chinese Han population, Shandong population and
Xuzhou population (allele frequency p=9.39610
25, 0.0271 and
3.47610
25, respectively). However, the logistic regression analysis
suggested that the association signal of SNP rs231775 was
accounted for the susceptibility variant SNP rs231779 in our
combined Chinese Han population. Unfortunately, another SNP
rs3087243 (CT60) was not in Hardy-Weinberg equilibrium (Table
S1) and was removed from the final analysis, which was similar to
the reported results from the Shanghai Chinese Han population
[28]. Notably, SNP rs3087243 was strongly linked with SNPs
rs231775 and rs231779 and the D’ values were more than 0.95 in
the Taiwan Chinese population [26]. Therefore, in our present
study, SNP rs3087243 may be tagged by SNPs rs231775 and
rs231779.
Although this study provides solid evidence for the association of
the CTLA4 gene with GD in our combined Chinese Han
population, it was notable that the susceptibility variants of the
CTLA4 gene might vary in the patients with GD recruited from
different geographic regions of China. In our case control analysis,
the loci with the most significant associations to GD were located
at SNP rs35219727 in the Shandong populations and rs231779 in
the Xuzhou and southern China populations, respectively.
Furthermore, the logistic regression analysis revealed that SNP
rs35219727 might be the susceptibility variant of GD in the
Shandong population. However, SNP rs231779 in the CTLA4
gene probably independently conferred GD susceptibility in the
combined Chinese Han population, Shandong and southern
China populations. A recent and detailed study of a Japanese GD
cohort investigated the SNPs across the TSHR region and
identified single SNP associations with GD primarily located in
intron 7 of TSHR [11]. However, in the more recent study by
Table 4. False positive report probability (FPRP) values for ten SNPs with significant difference between 2640 patients with GD
and 2204 health individuals.
SNP
Odds ratio
(95% CI)
Reported
p-Value
Statistical power under
recessive modela
Prior
probability
0.25 0.1 0.01 0.001 0.0001 0.00001
rs11571315 1.26 (1.15–1.39) 4.65610
26 0.9999 1.40610
25 4.19610
25 0.0005 0.0046 0.0444 0.3174
rs4553808 1.19 (1.05–1.36) 0.0127 0.9999 0.0366 0.1024 0.5566 0.9268 0.9922 0.9992
rs11571316 1.25 (1.11–1.39) 0.0004 0.9999 0.0013 0.0038 0.0399 0.2957 0.8078 0.9768
rs231775 1.24 (1.12–1.38) 9.39610
25 0.9999 0.0003 0.0008 0.0092 0.0857 0.4841 0.9037
rs231777 1.16 (1.03–1.32) 0.0288 1.0000 0.0795 0.2057 0.7402 0.9664 0.9965 0.9997
rs231779 1.35 (1.23–1.48) 2.81610
29 0.9956 8.46610
29 2.54610
28 2.79610
27 2.82610
26 2.82610
25 0.0003
rs231723 1.24 (1.13–1.36) 2.55610
25 1.0000 7.65610
25 0.0002 0.0025 0.0248 0.2032 0.7183
rs231725 1.26 (1.15–1.38) 2.86610
26 1.0000 8.58610
26 2.58610
25 0.0003 0.0029 0.0278 0.2225
rs11571302 1.26 (1.14–1.40) 2.29610
25 0.9998 6.88610
25 0.0002 0.0023 0.0224 0.1866 0.6964
rs231729 1.25 (1.15–1.36) 2.61610
26 1.0000 7.82610
26 2.35610
25 0.0003 0.0026 0.0254 0.2068
a Statistical power is the power to detect an odds ratio of 1.5 for the homozygotes with the rare genetic variant, with an a level equal to the reported p-Value. FPRP
values below 0.2 are in bold face.
doi:10.1371/journal.pone.0009821.t004
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with GD in the UK European ancestry cohort was found [20].
Interestingly, their data demonstrate that the strongest signals of
association with GD were within TSHR intron 1 in the UK
European ancestry cohort [20]. Recently, two independently
reports have shown that some intricately substructured is exists
northern Han, central Han, and southern Han in the Chinese
population. However, the genetic differentiation among these
clusters are very small (FST _ 0.0002,0.0009) [33,34]. In the
present study, the Xuzhou city is closed to Shandong province
(subjects was mainly rectuited from Jinan and Linyi cities) and
both of them belongs to the central Han population. In fact, the
genetic differentiation is the most small in the central Han
population in China [33,34]. Thus, it is not obvious that the results
were influenced by population substructure in the present study.
These data, combined with our findings, suggest that the
susceptibility variants of GD vary in populations from different
geographic regions. More detailed analysis of different populations
is needed to confirm this hypothesis.
Materials and Methods
Sample recruitment
A total of 2640 unrelated individuals with Graves’ disease (GD)
were recruited from different geographic regions of China. Among
them, the numbers of GD individuals in Shandong Province,
Xuzhou City, and southern China regions, including Shanghai
and Fujian Province, were 970, 841, and 829, respectively. The
control group was made up of 2204 unrelated healthy subjects
from the same geographic region screened for the absence of
thyroid disease. Within these subjects, 682, 818, and 704 control
subjects were collected from Shandong, Xuzhou, and southern
China. The diagnosis of GD was based on documented clinical
and biochemical evidence of hyperthyroidism, diffused goiter, and
the presence of at least one of the following items: positive TSH
receptor antibody tests, diffusely increased
131I (iodine-131) uptake
in the thyroid gland, or the presence of exophthalmos. All
individuals classified as affected were interviewed and examined by
experienced clinicians. All subjects were Chinese Han in origin.
After receiving informed consent, 5-ml blood samples were
collected from all participants for DNA preparations, as well as
for biochemical measurements.
Genotyping methodology, SNP selection, and quality
control (QC) filters
All genotyping was performed using the Mass-Array
TM Tech-
nology Platform of Sequenom, Inc (San Diego, California, USA). A
total of 63 SNPs were identified in the CTLA4 gene region from
NCBI dbSNP (NCBI Human Genome Build 36.3). Subsequently,
several procedures were taken for selecting these SNPs. Firstly,
SNPs associated with GD in the previous reports and tag SNPs
were selected. Secondly, SNPs were chosen with an average space
of 50 bp. Finally, several SNPs were removed through the assembly
of multiple-PCR primers. Accordingly, 47 SNPs in the CTLA4 gene
region in Supplementary Table S1 were genotyped for association
analysis in 2640 GD individuals and 2204 normal subjects,
collected from different geographic regions of China. Then several
steps were taken for the SNPs quality control (QC) filters. Firstly, 22
of 47 SNPs with a unique allele or minor allele frequency (MAF) of
less than 1% were removed from the association analysis. Secondly,
rs41265961,rs3087245, and rs7565213 were removed from the
analysis because of missing data above 20%. Finally, seven SNPs
with Hardy-Weinberg equilibria (HME) p#1610
26 in controls
were eliminated from the analysis [29].
Statistical analysis of association
In the case-control design, allele/genotype frequencies, odds
ratios (ORs), and significance values were analyzed by Chi-
square analysis using SPSS (version 13.0; SPSS Inc). In order to
exclude false positives, 20 neutral SNPs on different chromo-
somes were analyzed as genomic controls (GCs) and the GC
inflation factor (lGC) was 1.1734 [10]. All statistical results were
normalized to the GC. A p-value ,0.05 was considered
significant. The genotype data were further mined by logistic
regression analysis, as previously described [16,31]. Linkage
disequilibrium (LD) regions were analyzed by Haploview [30].
FPRP was analyzed using the FPRP calculation spreadsheet
provided by Wacholder, et al [24]. The statistical power to
detect an odds ratio of 1.5, with an a level equal to the reported
p-value was also provided and the FPRP value for noteworthi-
ness was preset to 0.5.
Supporting Information
Table S1
Found at: doi:10.1371/journal.pone.0009821.s001 (0.04 MB
PDF)
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